The patients in the intervention group showed significant improvement in the cortical activation when compared to the control group as measured by the change in oxyhemoglobin. At the end of 3 months HbO decreased in the control group(-0.6 + 6.6) whereas it increased in the intervention group(4.7 + 8.8) with a difference of -5.4, 95% Confidence Interval (CI) -9.4 to -1.4, p=0.008]. However, it failed to show a statistically significant difference in the clinical outcomes measured using Fugl Meyer Assessment Scale (90.8 + 30.9 and 101.8 + 26.0 in intervention and control group respectively with a difference of 10.9, 95% CI -3.7 to 25.6, p=0.14 ) and modified Rankin Scale (2.8 + 0.5 and 2.8 + 0.6 in intervention and control group respectively with 95% CI -0.3 to 0.2, p=0.79 ) in both the groups at the end of 3 months.